TKI-based regimens remain the primary approach for metastatic renal cell carcinoma after immune checkpoint inhibitor therapy, ...

The U.S. Food and Drug Administration said on Friday it approved new labeling for Sarepta Therapeutics' gene therapy Elevidys ...

Fondazione Telethon announces the positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the ...

In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol ...

These findings support the potential of AI-driven histopathological analysis as a biomarker in melanoma,” study researchers wrote.

Samson Clinical (Samson), an Australian pharmaceutical company focused on developing innovative treatments for hair loss, today announced the successful completion of recruitment in its SAM-002 Phase ...

Fondazione Telethon announces the positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommending marketing authorization in ...

In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory ...

Amid high demand for mental health care, some individuals have turned to AI chatbots for emotional support — but a new study ...

NEW ORLEANS – A single injection of a gene-edited protein was deemed productive and safe in patients with dyslipidemia that ...

Researchers assessed whether combination mosunetuzumab and polatuzumab vedotin would reduce the risk of disease progression or death in patients with LBCL.

In a 15-patient, Phase 1 one, first-in-human trial, a one-time, CRISPR-Cas9 gene-editing therapy safely reduced LDL ...